avelumab
pfizer,aura biosciences,merck
['mibc', ' aura ', 'avelumab', 'aura ']
avelumab as the basis of neoadjuvant regimen in platinum-eligible and -ineligible patients with nonmetastatic #mibc: aura (oncodistinct-004) trial. presented by . #asco22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology